Six Chinese Biotechs Bag $403m In Fresh Financing Rounds

fund raising
Chinese biotechs raise new funds for immuno-oncology therapies, neurodegenerative drugs, and vaccines. • Source: Alamy

More from China

More from Focus On Asia